Biocon to invest Rs 240 cr on acquisition

22867 Investors following Biocon. Share this News with them.

0

Like this story, share it with millions of investors on M3

Biocon to invest Rs 240 cr on acquisition

Biocon announced its Q3 FY08 result. The company held an analyst meet to discuss the same.

Post your opinion here

 

0

Tweet

Share on Tumblr

ALSO READ News and Notices about Biocon See interviews with Biocon Management See what other Experts & Brokerages are saying about Biocon See previous Results of Biocon Biocon BSE | NSE 28/05/12 Are Mutual Funds betting on Biocon?

Biocon announced its Q3 FY08 result. The company held an analyst meet to discuss the same. Few highlights are...

• Net profit down 3.54 % at Rs 53.35 Cr vs Rs 55.31 Cr, YoY
• OPM at 24.83% vs 31.43 %
• Operating profit at Rs 58.94 Cr vs Rs 77.47 Cr
• Net sales down 3.7 % at Rs 238.48 Cr vs Rs 246.48 Cr
• The Board has agreed in principle to list Syngene, Biocon's wholly owned research services company, on the Indian Stock Exchanges during FY 2008-09.
• The company mulls multiple acquisition, will invest Rs 240 cr for the same
• Syngene is a pioneer in contract research and is recognized as among Asia's largest CROs

For more details, listen to the concall...